نتائج البحث

Fracture risk following intermission of osteoporosis therapy

• Authors : Dennison, E. M.; Cooper, C.; Kanis, J. A.

Subjects: Atypical fracture; Bisphosphonates; Denosumab

• Source: Dennison , E M , Cooper , C , Kanis , J A , Bruyère , O , Silverman , S , McCloskey , E , Abrahamsen , B , Prieto-Alhambra , D , Ferrari , S & On behalf of the IOF Epidemiology/Quality of Life

تفاصيل العنوان

Total mandibulectomy defect in the setting of chronic bisphosphonate use

• Authors : Jategaonkar, Ameya A; Badhey, Arvind K; Sokoya, Mofiyinfolu

Subjects: Bone Density Conservation Agents (administration & dosage; adverse effects); Diphosphonates (administration & dosage

• Source: ENT and Skull Base Surgery

تفاصيل العنوان

International Osteoporosis Foundation and European Calcified Tissue Society Working Group. Recommendations for the screening of adherence to oral bisphosphonates

• Authors : Diez-Perez, Adolfo; Naylor, K E; Abrahamsen, B

Subjects: Adherence; Bisphosphonates; Osteoporosis treatment

• Source: Diez-Perez , A , Naylor , K E , Abrahamsen , B , Agnusdei , D , Brandi , M L , Cooper , C , Dennison , EM , Eriksen , E F , Gold , D T , Guañabens , N , Hadji , P , Hiligsmann , M , Horne , R , Josse

تفاصيل العنوان

Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE):survival results from an adaptive, multiarm, multistage, platform randomised controlled trial

Subjects: Adult; Aged; 80 and over

• Source: STAMPEDE Investigators 2016 , ' Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE) : survival results from an adaptive, multiarm,

تفاصيل العنوان

The effect of bisphosphonate treatment on osteoclast precursor cells in postmenopausal osteoporosis:The TRIO study

• Authors : Gossiel, F; Hoyle, C; McCloskey, E V

Subjects: Administration; Oral; Adult

• Source: Gossiel , F , Hoyle , C , McCloskey , E V , Naylor , K E , Walsh , J , Peel , N & Eastell , R 2016 , ' The effect of bisphosphonate treatment on osteoclast precursor cells in postmenopausal

تفاصيل العنوان

Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial.

• Authors : James, N.D.; Sydes, M.R.; Clarke, N.W. ...

Subjects: Adult; Aged; 80 and over

• Source: Lancet (London, England), vol. 387, no. 10024, pp. 1163-1177

تفاصيل العنوان

Incidence of stress fractures of the femoral shaft in women treated with bisphosphonate / Incidence of stress fractures of the femoral shaft in women treated with bisphosphonate

• Authors : Schilcher, J; Aspenberg, P

• Source: Acta Orthopaedica. 80(4):413

تفاصيل العنوان

Concomitant oral tyrosine kinase inhibitors and bisphosphonates in advanced renal cell carcinoma with bone metastases.

• Authors : Beuselinck, B; Wolter, P; Karadimou, A

Subjects: Sciences bio-médicales et agricoles; Antineoplastic Combined Chemotherapy Protocols -- adverse effects -- therapeutic use; Bone Density Conservation Agents -- administration & dosage -- adverse effects

• Source: British Journal of Cancer, 107 (10

تفاصيل العنوان

Management of fragility fractures in Switzerland: results of a nationwide survey.

• Authors : Suhm, N.; Lamy, O.; Lippuner, K. ...

Subjects: Absorptiometry; Photon; Acute Disease

• Source: Swiss medical weekly, vol. 138, no. 45-46, pp. 674-683

تفاصيل العنوان

Intravenous bisphosphonates in osteoporosis and jaw osteonecrosis: comment on the article by Delmas et al

• Authors : Landis, Basile Nicolas; Hugentobler, Max Anselme

Subjects: info:eu-repo/classification/ddc/616.8; info:eu-repo/classification/ddc/617; Bone Density Conservation Agents/administration & dosage/adverse effects

• Source: ISSN: 0004-3591 ; Arthritis and rheumatism, vol. 54, no. 11 (2006) p. 3720-3721;authorreply3721-2.

تفاصيل العنوان